Skip to main content

Table 4 miRNA-202-3p levels in the sera of control participants and in patients with type 1 g-NEN

From: Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms

miRNA-202-3p

Patient group (copies/nl)

Control group (copies/nl)

p

Mean

9.22 × 107

0.867 × 107

0.000

Median

3.84 × 107

0.635 × 107

 
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us